- The trend backdrop is active with a 17-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 60.58% based on similar historical setup states.
AMBEA
STO
Week ended 07 Aug 2026
Weekly Investor Report
Ambea AB (publ) · Healthcare · Medical Care Facilities
Latest close
143.0 SEK
-0.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 4.6% above the Trend Line and sits at 65.7% of its 52-week range. The latest completed week returned -0.9%, after a 0.3% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.
Setup score
51
out of 100
Latest Close
143.0 SEK
7 Aug 2026
1W Return
-0.9%
latest completed week
4W Return
0.3%
short-term follow-through
12W Return
-2.1%
quarterly tape
Trend Breadth
82.7%
43 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 13 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.9%
Latest completed week; four-week move 0.3%.
Indicator stack
90/30
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 60.58%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
9 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 4.6% above the Trend Line and sits at 65.7% of its 52-week range. The latest completed week returned -0.9%, after a 0.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6112-week average 0.77
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.61Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1313 reversal markers
No recent accumulation markers. 13 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.3% over four weeks, -2.1% over 12 weeks, and 23.0% over one year. The current trend has remained active for 17 consecutive weeks.
Performance by holding period
Active trend streak17 weeks
Active weeks in one year43
Trend breadth82.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.25Latest activity-pressure read.
Pressure change-195.4%Four-week change in activity pressure.
Leadership-4.80Latest relative-leadership reading.
RS change-285.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 9 relevant articles.
3 positive · 6 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.6%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher17 of 269 weeks finished lower.
Best week+12.9%Week of 3 Jul.
Worst week-17.2%Week of 13 Feb.
Latest week-0.9%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains12
Flat weeks0
Modest losses5
Sharp losses4
Recent vol5.3%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank44 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Medical Care Facilities
4-week rank2 / 4
Group average0.8%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD50.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape53/100
Trend, activity pressure, participation, and risk combine to a 53/100 tape read.
Indicator analysis60/100Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 4/12.
Activity pressure 0.61; 13 reversal markers Next-Week ExpectancyPositive 60.58%Next-week expectancy is positive with a 60.58% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 9 relevant articles.
Humana AB surges 25% after peer Ambea launches $304 million takeover bid Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 143.0 SEK | -0.9% | 136.7 SEK | 95.52 SEK | -0.25 | -4.80 | 391.9K | On |
| 31 Jul 2026 | 144.3 SEK | 2.9% | 136.5 SEK | 94.82 SEK | -0.07 | -2.06 | 423.0K | On |
| 24 Jul 2026 | 140.2 SEK | -3.2% | 136.2 SEK | 94.12 SEK | 0.22 | -3.53 | 392.1K | On |
| 17 Jul 2026 | 144.8 SEK | 1.5% | 136.2 SEK | 93.42 SEK | 0.27 | 1.24 | 455.2K | On |
| 10 Jul 2026 | 142.6 SEK | -8.9% | 136.0 SEK | 92.71 SEK | 0.27 | -1.24 | 833.8K | On |
| 3 Jul 2026 | 156.6 SEK | 12.9% | 135.7 SEK | 91.99 SEK | 0.22 | 6.09 | 353.7K | On |
| 26 Jun 2026 | 138.7 SEK | 4.6% | 134.8 SEK | 91.20 SEK | 0.09 | -3.14 | 59.7K | On |
| 19 Jun 2026 | 132.6 SEK | -5.3% | 134.8 SEK | 90.52 SEK | 0.38 | -8.14 | 894.0K | On |
| 12 Jun 2026 | 140.0 SEK | -1.1% | 134.7 SEK | 89.88 SEK | 0.64 | -1.11 | 57.0K | On |
| 5 Jun 2026 | 141.6 SEK | -5.8% | 134.2 SEK | 89.20 SEK | 0.80 | -0.04 | 204.6K | On |
| 29 May 2026 | 150.3 SEK | 1.1% | 133.6 SEK | 88.51 SEK | 0.96 | 5.45 | 447.2K | On |
| 22 May 2026 | 148.6 SEK | 1.8% | 132.8 SEK | 87.76 SEK | 0.77 | 4.25 | 570.6K | On |
| 15 May 2026 | 146.0 SEK | 1.4% | 132.0 SEK | 87.03 SEK | 0.54 | 6.34 | 497.5K | On |
| 8 May 2026 | 144.0 SEK | 4.6% | 131.3 SEK | 86.32 SEK | 0.25 | 3.87 | 1.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.